On­line

Irish Examiner - Feelgood - - This Week -

BREAK­ING CAN­CER: A new treat­ment halts the spread of can­cer by “break­ing the legs” of tu­mour cells. Sci­en­tists used tiny gold rods to smash the leg-like pro­tru­sions called filopo­dia that help can­cer cells up-an­chor and move. Lab­o­ra­tory tests on hu­man can­cer cells showed that ren­der­ing them limb­less thwarted their abil­ity to mi­grate and spread, or metas­ta­sise. It is the deadly spread of tu­mours to vi­tal organs such as the liver or brain that is most likely to kill a can­cer pa­tient. Tar­get­ing filopo­dia, which ex­tend out from a weave of fi­bres called lamel­lipo­dia on the cell’s fringes, could be a gamechanger in the fight against metas­ta­sis, the sci­en­tists be­lieve. No toxic ef­fects were seen from the gold treat­ment, and healthy cells — which also need to move — were not harmed, said the re­searchers writ­ing in the jour­nal Pro­ceed­ings of the Na­tional Academy of Sci­ences. ASPIRIN BOOST: Tak­ing a low­dose aspirin be­fore bed can re­duce the risk of the po­ten­tially fa­tal con­di­tion pre-eclamp­sia. Doc­tors have dis­cov­ered that ad­min­is­ter­ing 150mg of aspirin led to a 62% re­duc­tion in the rate of preterm pre-eclamp­sia, re­sult­ing in a de­liv­ery be­fore 37 weeks. The study found an 82% re­duc­tion in the rate of early preeclamp­sia, re­sult­ing in a de­liv­ery be­fore 34 weeks. The trial of 1,776 women at high risk for pre-term pre-eclamp­sia found a lower in­ci­dence of de­vel­op­ing the dis­ease in women tak­ing aspirin than those tak­ing a placebo. Pre-eclamp­sia can cause pre­ma­ture birth and, in ex­treme cases, ma­ter­nal and foetal death. FLU FIGHTER: A patch has been de­vel­oped which could re­place tra­di­tional flu jabs. The new tech­nol­ogy could lead to peo­ple im­mu­nis­ing them­selves against flu at home and would re­duce dan­ger­ous waste from hy­po­der­mic nee­dles.

The patch looks like a plas­ter and is worn by pa­tients for 20 min­utes on the wrist while mi­cronee­dles which con­tain the im­mu­ni­sa­tion dis­solve. It was sub­ject of a study pub­lished in the Lancet of 100 peo­ple in the United States with 70% pre­fer­ring the patch to a tra­di­tional in­jec­tion.

Newspapers in English

Newspapers from Ireland

© PressReader. All rights reserved.